Tolerance.ca
Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

BMI shouldn’t be the only way to assess who can access weight-loss drugs

By Liz Sturgiss, Professor of Community Medicine and Clinical Education, Bond University
Kimberley Norman, Research Fellow, Obesity and Weight Management, Monash University
Around one in three Australian adults (32%) has a body-mass index (BMI) of 30 or above. A further 34% has a BMI of 25 or above.

Australia’s regulator has approved Wegovy, the weight-loss version of Ozempic (semaglutide) and MounjaroThe Conversation


Read complete article

© The Conversation -
Subscribe to Tolerance.ca


Follow us on ...
Facebook Twitter